版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領
文檔簡介
EPIDEMIOLOGYOFCARDIOVASCULARDISEASE(CVD)PublicHealthBETTINAPIKO,M.D.,Ph.D.EPIDEMIOLOGYOFCARDIOVASCULAR1
?Cardiovasculardiseasehasthesamemeaningforhealthcaretodayastheepidemicsofcenturieshadformedicineinearliertimes:50%ofthepopulationindevelopedcountriesdieofcardiovasculardisease”(PálKertai)
Someonehasaheartattackeverytwominutes(BritishHeartFoundation)
?Cardiovasculardiseasehast2PublicHealthSignificance-Leadingcauseofmortalityindevelopedcountriesandarisingtendencyindevelopingcountries(diseaseofcivilization)-Amajorimpactonlifeexpectancy-Significantlycontributestomorbidityanddeathratesinthemiddleagedpopulation:potentiallifeyearslost,commoncauseofprematuredeath,laborforce(economiccosts),familylife-Morbidity:nearly30%ofalldisabilitycases-ContributestodeteriorationofthequalityoflifePublicHealthSignificance-Le3【高血壓英文課件】-心血管疾病的流行病學4【高血壓英文課件】-心血管疾病的流行病學5PartsofCardiovascularEpidemiology1.,Descriptiveepidemiology:=Describingdistributionofcardiovasculardiseasebymeansofcertaincharacteristicssuchas:PERSON(i.e.,age,gender,ethnicity)TIMEandPLACE2.,Analyticepidemiology=AnalyzingrelationshipsbetweenCVDandriskfactors(whichelevatetheprobabilityofadiseaseatpopulationlevel),riskmodelandmulticausaldevelopments3.,Experimentalepidemiology/Interventions=Strategiesofcardiovascularprevention(primordial,primary,secondary,tertiary;individualandcommunitylevels)PartsofCardiovascularEpidem6DescriptiveEpidemiologyI.DistributionPatternsintheWorldIntheworld:CVDdeathsaccountforonethirdofalldeaths(25-50%dependingonthelevelofeconomicdevelopment)amongwhich50%:coronarydeathsCVDmadeup16.7millionofglobaldeathsin2002,amongwhich7millionduetocoronaryheartdisease,6millionduetostrokeDistributionoftypesofCVDinglobaldeaths:Globalcardiovasculardeathsin2002:16.7millionamongwhich:coronaryheartdisease7.2million>stroke6.0million>0.9millionhypertensiveheartdisease>0.4millioninflammatoryheartdisease>0.3millionrheumaticheartdisease>1.9millionotherCVDDescriptiveEpidemiologyI.D7DescriptiveEpidemiologyII.AGEQuestion:WhatistherelativeamountofCVDindeathratesindifferentagegroups?-Earlylesionsofbloodvessel,atheroscleroticplaques:around20years-adultlifestylepatternsusuallystartinchildhoodandyouth(smoking,dietaryhabits,sportingbehavior,etc.)-IncreaseinCVDmorbidityandmortality:inage-groupof30-44years-Prematuredeath(<64yearsofage,or25-64years):intheelderlypopulationmoredifficulttointerpretdeathrateduetomultipleillhealthcausesDescriptiveEpidemiologyII.A84,6%11,4%22,5%61,5%32,7%26,9%26,0%14,0%55,8%24,6%14,9%4,7%0%10%20%30%40%50%60%70%80%90%100%1-24yrs25-64yrs>65yrsPROPORTIONOFMORTALITYINDIFFERENTAGE-GROUPS(MEN)
externalotherscancerCVD4,6%11,4%22,5%61,5%32,7%26,9%297,3%17,7%35,0%40,0%31,3%36,5%24,0%8,2%64,7%12,2%18,3%4,8%0%10%20%30%40%50%60%70%80%90%100%1-24yrs25-64yrs>65yrsPROPORTIONOFMORTALITYINDIFFERENTAGE-GROUPS(WOMEN)externalotherscancerCVD7,3%17,7%35,0%40,0%31,3%36,5%210DescriptiveEpidemiologyIII.SEXQuestion:WhatistherelativeamountofCVDindeathratesinwomenandmen?-Widespreadidea:CVDisoftenthoughttobeadiseaseofmiddle-agedmen.-Cardiovascularmortality(fatalcases)aremorecommonamongmen.However,CVDaffectnearlyasmanywomenasmen,albeitatanolderage-Women:specialcase(WHO,2004)a.,Higherriskinwomenthanmen(smoking,hightriglyceridelevels)b.,Higherprevalenceofcertainriskfactorsinwomen(diabetesmellitus,depression)c.,Gender-specificriskfactors(risksforwomenonly)(oralcontraceptives,hormonereplacementtherapy,polycysticovarysyndrome)DescriptiveEpidemiologyIII.11SDR,coronaryheartdiseaseinselectedEuropeancountriesbygender,0-64yrs,per1000000SDR,coronaryheartdiseasein12DescriptiveEpidemiologyIV.ETHNICITYQuestion:WhatistherelativeamountofCVDindeathratesindifferentethnicgroups?-IntheUS:increasedcardiovasculardiseasedeathsinAfrican-AmericanandSouth-AsianpopulationsincomparisonwithWhites-IncreasedstrokeriskinAfrican-American,someHispanicAmerican,Chinese,andJapanesepopulations-Migration:Ni-Hon-SanStudy:JapaneselivinginJapanhadthelowestratesofCHDandcholesterollevels,thoselivinginHawaiihadintermediateratesforboth,thoselivinginSanFranciscohadthehighestratesforbothDescriptiveEpidemiologyIV.E13DescriptiveEpidemiologyV.TIMEandPLACEQuestion:WhatistherelativeamountofCVDindifferentgeographicalplaces?Whatarethetimetrends?InternationalandregionalcharacteristicsofdistributionSDR:StandardizedDeathRateDirectmodeofstandardization,usingtheagedistributionofahypotheticalEuropeanstandardpopulationPrematuredeathratesforcomparisonpurposes(<64yearsofage)DescriptiveEpidemiologyV.14DescriptiveEpidemiologyVI.
WorldTrendsDevelopedcountries:decreasingtendencies(e.g,USA:30%between1988-98,Sweden:42%)-improvementoflifestylefactors,forexample,adecreaseofsmokingandahigherlevelofhealthconsciousnessinmanydevelopedcountries-betterdiagnosticandtherapeuticprocedures(e.g.,bypasssurgeries,hypertensionscreening,pharmacologicaltreatmentofhypertensionandhypercholesterinaemia,accesstohealthcare)Developingcountries:increasingtendencies-increasinglongevity,urbanization,andwesterntypelifestyleDescriptiveEpidemiologyVI.
15DescriptiveEpidemiologyVII.InternationalComparisonsAims:a.,Wherearetherateshigherorlower?b.,Interpretationoftimetrendsc.,InequalitiesincardiovasculardeathDescriptiveEpidemiologyVII.16CardiovasculardeathsinEurope
(SDR,2000)CardiovasculardeathsinEurop17SDR,diseasesofcirculatorysysteminWesternEurope,0-64yrs,per1000000
EU-15average
UnitedKingdom
Switzerland
Spain
Netherlands
Italy
Greece
France
Finland
Denmark
Austria
SDR,diseasesofcirculatorys18SDR,diseasesofcirculatorysysteminEasternEurope,0-64yrs,per1000000
EU-15average(MSsprior1.5.2004)
Slovakia
RussianFederation
Romania
Hungary
Croatia
SDR,diseasesofcirculatorys19SDR,diseasesofcirculatorysysteminHungary,0-64yrs,per1000000
Finland
Hungary
EU-15averageSDR,diseasesofcirculatorys20AnalyticEpidemiologyI.
RoleofRiskFactorsOver300riskfactorshavebeenassociatedwithcoronaryheartdisease,hypertensionandstrokeApprox.75%ofCVDcanbeattributedtoconventionalriskfactorsRiskfactorsofgreatpublichealthsignificance:-highprevalenceinmanypopulations-greatindependentimpactonCVDrisk-theircontrolandtreatmentresultinreducedCVDriskDevelopingcountries:doubleburdenofrisks(problemsofundernutritionandinfections+CVDrisks)AnalyticEpidemiologyI.
Role21AnalyticEpidemiologyII.
ClassificationofRiskFactorsMajormodifiableriskfactorsHighbloodpressureAbnormalbloodlipidsTobaccousePhysicalinactivityObesityUnhealthydietDiabetesmellitusOthermodifiableriskfactorsLowsocioeconomicstatusMentalillhealth(depression)PsychosocialstressHeavyalcoholuseUseofcertainmedicationLipoprotein(a)Non-modifiableriskfactorsAgeHeredityorfamilyhistoryGenderEthnicityorrace”Novel”riskfactorsExcesshomocysteineinbloodInflammatorymarkers(C-reactiveprotein)Abnormalbloodcoagulation(elevatedbloodlevelsoffibrinogen)AnalyticEpidemiologyII.
Cla22AnalyticEpidemiologyIII.Hypertension-Systolicbloodpressure>140Hgmmand/oradiastolicbloodpressure>90Hgmm-Freeofclinicalsymptomsformanyyears(screening)-Inmostcountries,upto30percentofadultssuffering,increasingwithageincivilizedcountries-Positivefamilyhistory-Dietaryhabits(ahighintakeofsalt,processedfood,lowlevelsofwaterhardness,highthyraminecontentoffood,alcoholuse)-Modernlifestyle(increasedsympatheticactivity,psychosocialstress,leadingpositioninjob)AnalyticEpidemiologyIII.Hyp23AnalyticEpidemiologyIV.
RheumaticFeverandRheumaticHeartDiseaseDevelopment:Rheumaticfeverusuallyfollowsanuntreatedbeta-haemolyticstreptococcalthroatinfectioninchildrenAsaconsequence,theheartvalvesarepermanentlydamagedwhichmayprogresstoheartfailureTodaymostlyaffectschildrenindevelopingcountries,linkedtopoverty,inadequacyofhealthcareaccessOccurrence:12millionpeoplecurrentlyaffectedbyrheumaticfeverandRHD,two-thirdsarechildren(5-15years),forexample:approx.1000000inSub-SaharanAfrica,700000inSouth-CentralAsia,176000inChina,150000inNorthAfrica,40000inEasternEurope(!)AnalyticEpidemiologyIV.
Rhe24AnalyticEpidemiologyV.AbnormalBloodLipids-Secholesterol:structureandfunctioningofbloodvessels,atheroscleroticplaques-Alteringfunctionsofcholesterolfractions(LDL:risk,HDL:protection)-Estrogen:tendstoraiseHDL-cholesterolandlowerLDL-cholesterol,protectionforwomeninreproductiveage-Partiallygeneticdeterminationofmetabolism,partiallydependentofnutrition(egg,meats,dairyproducts)AnalyticEpidemiologyV.25CurrentRecommendedLipidLevelsEuropeanguidelinesUSguidelinesTotalcholesterol<5.0mmol/l<240mg/dl(6.2mmol/l)LDL-cholesterol<3.0mmol/l<160mg/dl(3.8mmol/l)HDL-cholesterol>=1.0mmol/l(men)>=1.2mmol/l(women)>=40mg/dl(1mmol/l)Triglycerides(fasting)<1.7mmol/l<200mg/dl(2.3mmol/l)CurrentRecommendedLipidLeve26AnalyticEpidemiologyVI.
TobaccoUse-ThelinkbetweensmokingandCVD(mainlyCHD)wasidentifiedin1940-Greatestrisk:initiation<16years-Passivesmoking:additionalrisk-Womensmokers:areathigherriskofCHDandCVDthanmalesmokers-Severalmechanisms:damagestheendotheliumlining,increasesatheroscleroticplaques,raisesLDLandlowersHDL,promotesarteryspasms,raisesoxigendemandoftheheartmuscle-Nicotineacceleratestheheartrate(RR),andraisesbloodpressureAnalyticEpidemiologyVI.
Tob27AnalyticEpidemiologyVII.PhysicalInactivity-Regularphysicalactivity:protectivefactor-Intensityandduration(150minutes/weekintermediateor60minutes/weekheavy)-Modernization,urbanization,mechanizedtransport:sedentarylifestyle(60%ofglobalpopulation)-RaisesCVDriskandalsothedevelopmentofotherriskfactors(glucosemetabolism,diabetesmellitus,bloodcoagulation,obesity,highbloodpressure,worseninglipidprofile)-Physicalactivity:helpsreducestress,anxietyanddepressionAnalyticEpidemiologyVII.28AnalyticEpidemiologyVIII.
Obesity,DiabetesMellitus,UnhealthyDiet
-BodyMassIndex:>25:overweight,>30:obesity-Amodern”epidemic”:Morethan60%ofadultsintheUSareoverweightorobese,inChina:70millionoverweightpeople-ElevatestheriskofbothCVDanddiabetesmellitus-Diabetesmellitus:damagesbothperipheralandcoronarybloodvessels-Unhealthydiet:lowfruitandvegetable,fibercontent,andhighsaturatedfatintake,refinedsugarAnalyticEpidemiologyVIII.
O29AnalyticEpidemiologyIX.Psychologicalandsocialfactors-Psychologicalfactors(TypeAbehavior,hostility)-DepressionandCVD:bidirectionallinka.,depressionmayincreasetheriskofCVDandworsenrecoveryprocessb.,CVDmayinducedepression-Lowsocioeconomicstatus(SES):a.,indevelopedcountries:lesseducatedandlowerSESgroups(accumulationofriskfactors)b.,indevelopingcountries:moreeducatedandhigherSESgroups(westernlifestyle)AnalyticEpidemiologyIX.Psy30CardiovascularPreventionI.Primordial:Social,legalandother(oftennonmedical)activitieswhichmayleadtoaloweringofriskfactors(e.g.,socioeconomicdevelopment,smoke-freerestaurants)Primary:ControllingriskfactorscontributingtoCVD(healtheducationprograms,anti-smokingcampaign,sportsprograms,nutritioncounselling,regularcheckofbloodpressureandcertainbloodparameters,e.g.,cholesterol,bloodlipids,glucose)Secondary:Screeningandtreatmentofsymptomaticpatients,setuppersonalriskprofileTertiary:Cardiovascularrehabilitation,preventionofrecurrenceofCVD(newheartattack:5-7timeshigherriskamongCVDpatients)CardiovascularPreventionI.Pr31CardiovascularPreventionII.Theindividualapproach(detectingthoseatgreatestrisk):lifestyleguidelines(e.g.,smokingcessation)Thepopulation-wideapproach:(thewholepopulation,westernlifestyle)Exampleforcommunity-wideCVpreventionprograms:-FraminghamHeartStudy(1948-)FraminghamRiskScoring-North-KareliaProject(1972-)Finland-StanfordProjects(1972-75,1980-86)USA-MinnesotaCardiovascularHealthProgram(1980-88)USA-MultipleRiskfactorInterventionTrial(1972-79)USACardiovascularPreventionII.T32ReviewQuestions(DevelopedbytheSupercourseteam)WhatmaybethereasonsforthedecliningCVDincidencerates?Atthesametimethattherehasbeenanepidemicofobesity,theratesofCVDhasmarkedlydeclined.Whyhasn’tCVDgoupinthepopulationasobesityhasskyrocketed?DefinethestepstopreventCHDReviewQuestions(Developedby33EPIDEMIOLOGYOFCARDIOVASCULARDISEASE(CVD)PublicHealthBETTINAPIKO,M.D.,Ph.D.EPIDEMIOLOGYOFCARDIOVASCULAR34
?Cardiovasculardiseasehasthesamemeaningforhealthcaretodayastheepidemicsofcenturieshadformedicineinearliertimes:50%ofthepopulationindevelopedcountriesdieofcardiovasculardisease”(PálKertai)
Someonehasaheartattackeverytwominutes(BritishHeartFoundation)
?Cardiovasculardiseasehast35PublicHealthSignificance-Leadingcauseofmortalityindevelopedcountriesandarisingtendencyindevelopingcountries(diseaseofcivilization)-Amajorimpactonlifeexpectancy-Significantlycontributestomorbidityanddeathratesinthemiddleagedpopulation:potentiallifeyearslost,commoncauseofprematuredeath,laborforce(economiccosts),familylife-Morbidity:nearly30%ofalldisabilitycases-ContributestodeteriorationofthequalityoflifePublicHealthSignificance-Le36【高血壓英文課件】-心血管疾病的流行病學37【高血壓英文課件】-心血管疾病的流行病學38PartsofCardiovascularEpidemiology1.,Descriptiveepidemiology:=Describingdistributionofcardiovasculardiseasebymeansofcertaincharacteristicssuchas:PERSON(i.e.,age,gender,ethnicity)TIMEandPLACE2.,Analyticepidemiology=AnalyzingrelationshipsbetweenCVDandriskfactors(whichelevatetheprobabilityofadiseaseatpopulationlevel),riskmodelandmulticausaldevelopments3.,Experimentalepidemiology/Interventions=Strategiesofcardiovascularprevention(primordial,primary,secondary,tertiary;individualandcommunitylevels)PartsofCardiovascularEpidem39DescriptiveEpidemiologyI.DistributionPatternsintheWorldIntheworld:CVDdeathsaccountforonethirdofalldeaths(25-50%dependingonthelevelofeconomicdevelopment)amongwhich50%:coronarydeathsCVDmadeup16.7millionofglobaldeathsin2002,amongwhich7millionduetocoronaryheartdisease,6millionduetostrokeDistributionoftypesofCVDinglobaldeaths:Globalcardiovasculardeathsin2002:16.7millionamongwhich:coronaryheartdisease7.2million>stroke6.0million>0.9millionhypertensiveheartdisease>0.4millioninflammatoryheartdisease>0.3millionrheumaticheartdisease>1.9millionotherCVDDescriptiveEpidemiologyI.D40DescriptiveEpidemiologyII.AGEQuestion:WhatistherelativeamountofCVDindeathratesindifferentagegroups?-Earlylesionsofbloodvessel,atheroscleroticplaques:around20years-adultlifestylepatternsusuallystartinchildhoodandyouth(smoking,dietaryhabits,sportingbehavior,etc.)-IncreaseinCVDmorbidityandmortality:inage-groupof30-44years-Prematuredeath(<64yearsofage,or25-64years):intheelderlypopulationmoredifficulttointerpretdeathrateduetomultipleillhealthcausesDescriptiveEpidemiologyII.A414,6%11,4%22,5%61,5%32,7%26,9%26,0%14,0%55,8%24,6%14,9%4,7%0%10%20%30%40%50%60%70%80%90%100%1-24yrs25-64yrs>65yrsPROPORTIONOFMORTALITYINDIFFERENTAGE-GROUPS(MEN)
externalotherscancerCVD4,6%11,4%22,5%61,5%32,7%26,9%2427,3%17,7%35,0%40,0%31,3%36,5%24,0%8,2%64,7%12,2%18,3%4,8%0%10%20%30%40%50%60%70%80%90%100%1-24yrs25-64yrs>65yrsPROPORTIONOFMORTALITYINDIFFERENTAGE-GROUPS(WOMEN)externalotherscancerCVD7,3%17,7%35,0%40,0%31,3%36,5%243DescriptiveEpidemiologyIII.SEXQuestion:WhatistherelativeamountofCVDindeathratesinwomenandmen?-Widespreadidea:CVDisoftenthoughttobeadiseaseofmiddle-agedmen.-Cardiovascularmortality(fatalcases)aremorecommonamongmen.However,CVDaffectnearlyasmanywomenasmen,albeitatanolderage-Women:specialcase(WHO,2004)a.,Higherriskinwomenthanmen(smoking,hightriglyceridelevels)b.,Higherprevalenceofcertainriskfactorsinwomen(diabetesmellitus,depression)c.,Gender-specificriskfactors(risksforwomenonly)(oralcontraceptives,hormonereplacementtherapy,polycysticovarysyndrome)DescriptiveEpidemiologyIII.44SDR,coronaryheartdiseaseinselectedEuropeancountriesbygender,0-64yrs,per1000000SDR,coronaryheartdiseasein45DescriptiveEpidemiologyIV.ETHNICITYQuestion:WhatistherelativeamountofCVDindeathratesindifferentethnicgroups?-IntheUS:increasedcardiovasculardiseasedeathsinAfrican-AmericanandSouth-AsianpopulationsincomparisonwithWhites-IncreasedstrokeriskinAfrican-American,someHispanicAmerican,Chinese,andJapanesepopulations-Migration:Ni-Hon-SanStudy:JapaneselivinginJapanhadthelowestratesofCHDandcholesterollevels,thoselivinginHawaiihadintermediateratesforboth,thoselivinginSanFranciscohadthehighestratesforbothDescriptiveEpidemiologyIV.E46DescriptiveEpidemiologyV.TIMEandPLACEQuestion:WhatistherelativeamountofCVDindifferentgeographicalplaces?Whatarethetimetrends?InternationalandregionalcharacteristicsofdistributionSDR:StandardizedDeathRateDirectmodeofstandardization,usingtheagedistributionofahypotheticalEuropeanstandardpopulationPrematuredeathratesforcomparisonpurposes(<64yearsofage)DescriptiveEpidemiologyV.47DescriptiveEpidemiologyVI.
WorldTrendsDevelopedcountries:decreasingtendencies(e.g,USA:30%between1988-98,Sweden:42%)-improvementoflifestylefactors,forexample,adecreaseofsmokingandahigherlevelofhealthconsciousnessinmanydevelopedcountries-betterdiagnosticandtherapeuticprocedures(e.g.,bypasssurgeries,hypertensionscreening,pharmacologicaltreatmentofhypertensionandhypercholesterinaemia,accesstohealthcare)Developingcountries:increasingtendencies-increasinglongevity,urbanization,andwesterntypelifestyleDescriptiveEpidemiologyVI.
48DescriptiveEpidemiologyVII.InternationalComparisonsAims:a.,Wherearetherateshigherorlower?b.,Interpretationoftimetrendsc.,InequalitiesincardiovasculardeathDescriptiveEpidemiologyVII.49CardiovasculardeathsinEurope
(SDR,2000)CardiovasculardeathsinEurop50SDR,diseasesofcirculatorysysteminWesternEurope,0-64yrs,per1000000
EU-15average
UnitedKingdom
Switzerland
Spain
Netherlands
Italy
Greece
France
Finland
Denmark
Austria
SDR,diseasesofcirculatorys51SDR,diseasesofcirculatorysysteminEasternEurope,0-64yrs,per1000000
EU-15average(MSsprior1.5.2004)
Slovakia
RussianFederation
Romania
Hungary
Croatia
SDR,diseasesofcirculatorys52SDR,diseasesofcirculatorysysteminHungary,0-64yrs,per1000000
Finland
Hungary
EU-15averageSDR,diseasesofcirculatorys53AnalyticEpidemiologyI.
RoleofRiskFactorsOver300riskfactorshavebeenassociatedwithcoronaryheartdisease,hypertensionandstrokeApprox.75%ofCVDcanbeattributedtoconventionalriskfactorsRiskfactorsofgreatpublichealthsignificance:-highprevalenceinmanypopulations-greatindependentimpactonCVDrisk-theircontrolandtreatmentresultinreducedCVDriskDevelopingcountries:doubleburdenofrisks(problemsofundernutritionandinfections+CVDrisks)AnalyticEpidemiologyI.
Role54AnalyticEpidemiologyII.
ClassificationofRiskFactorsMajormodifiableriskfactorsHighbloodpressureAbnormalbloodlipidsTobaccousePhysicalinactivityObesityUnhealthydietDiabetesmellitusOthermodifiableriskfactorsLowsocioeconomicstatusMentalillhealth(depression)PsychosocialstressHeavyalcoholuseUseofcertainmedicationLipoprotein(a)Non-modifiableriskfactorsAgeHeredityorfamilyhistoryGenderEthnicityorrace”Novel”riskfactorsExcesshomocysteineinbloodInflammatorymarkers(C-reactiveprotein)Abnormalbloodcoagulation(elevatedbloodlevelsoffibrinogen)AnalyticEpidemiologyII.
Cla55AnalyticEpidemiologyIII.Hypertension-Systolicbloodpressure>140Hgmmand/oradiastolicbloodpressure>90Hgmm-Freeofclinicalsymptomsformanyyears(screening)-Inmostcountries,upto30percentofadultssuffering,increasingwithageincivilizedcountries-Positivefamilyhistory-Dietaryhabits(ahighintakeofsalt,processedfood,lowlevelsofwaterhardness,highthyraminecontentoffood,alcoholuse)-Modernlifestyle(increasedsympatheticactivity,psychosocialstress,leadingpositioninjob)AnalyticEpidemiologyIII.Hyp56AnalyticEpidemiologyIV.
RheumaticFeverandRheumaticHeartDiseaseDevelopment:Rheumaticfeverusuallyfollowsanuntreatedbeta-haemolyticstreptococcalthroatinfectioninchildrenAsaconsequence,theheartvalvesarepermanentlydamagedwhichmayprogresstoheartfailureTodaymostlyaffectschildrenindevelopingcountries,linkedtopoverty,inadequacyofhealthcareaccessOccurrence:12millionpeoplecurrentlyaffectedbyrheumaticfeverandRHD,two-thirdsarechildren(5-15years),forexample:approx.1000000inSub-SaharanAfrica,700000inSouth-CentralAsia,176000inChina,150000inNorthAfrica,40000inEasternEurope(!)AnalyticEpidemiologyIV.
Rhe57AnalyticEpidemiologyV.AbnormalBloodLipids-Secholesterol:structureandfunctioningofbloodvessels,atheroscleroticplaques-Alteringfunctionsofcholesterolfractions(LDL:risk,HDL:protection)-Estrogen:tendstoraiseHDL-cholesterolandlowerLDL-cholesterol,protectionforwomeninreproductiveage-Partiallygeneticdeterminationofmetabolism,partiallydependentofnutrition(egg,meats,dairyproducts)AnalyticEpidemiologyV.58CurrentRecommendedLipidLevelsEuropeanguidelinesUSguidelinesTotalcholesterol<5.0mmol/l<240mg/dl(6.2mmol/l)LDL-cholesterol<3.0mmol/l<160mg/dl(3.8mmol/l)HDL-cholesterol>=1.0mmol/l(men)>=1.2mmol/l(women)>=40mg/dl(1mmol/l)Triglycerides(fasting)<1.7mmol/l<200mg/dl(2.3mmol/l)CurrentRecommendedLipidLeve59AnalyticEpidemiologyVI.
TobaccoUse-ThelinkbetweensmokingandCVD(mainlyCHD)wasidentifiedin1940-Greatestrisk:initiation<16years-Passivesmoking:additionalrisk-Womensmokers:areathigherriskofCHDandCVDthanmalesmokers-Severalmechanisms:damagestheendotheliumlining,increasesatheroscleroticplaques,raisesLDLandlowersHDL,promotesarteryspasms,raisesoxigendemandoftheheartmuscle-Nicotineacceleratestheheartrate(RR),andraisesbloodpressureAnalyticEpidemiologyVI.
Tob60AnalyticEpidemiologyVII.PhysicalInactivity-Regularphysicalactivity:protectivefactor-Intensityandduration(150minutes/weekintermediateor60minutes/weekheavy)-Modernization,urbanization,mechanizedtransport:sedentarylifestyle(60%ofglobalpopulation)-RaisesCVDriskandalsothedevelopmentofotherriskfactors(glucosemetabolism,diabetes
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024房地產(chǎn)交易委托服務協(xié)議書大全
- 二零二五年度個人合伙環(huán)保技術(shù)合作合同范本3篇
- 二零二五年度跨國公司總經(jīng)理職位聘用協(xié)議3篇
- 二零二五年度IT培訓與外包服務合同2篇
- 2025版酒吧店長任期考核與激勵合同范本3篇
- 二零二五年度保密技術(shù)培訓保密合同模板2篇
- 二零二五年度醫(yī)療廢物處理與處置合同示例2篇
- 2024年獨家銷售外企商品代理協(xié)議3篇
- 2025版酒店用品租賃及售后服務合同3篇
- 2024版離婚父母子女撫養(yǎng)義務與探視權(quán)合同版B版
- 術(shù)后惡心嘔吐防治專家共識(全文)
- 公共政策學政策分析的理論方法和技術(shù)課件
- 教案:孔門十弟子
- 中醫(yī)藥在肝癌介入治療中的作用課件
- 超短波操作流程圖
- 小學2022 年國家義務教育質(zhì)量監(jiān)測工作方案
- 化學品安全技術(shù)說明(膠水)
- 總工會新規(guī)慰問標準
- 西師大版四年級音樂上冊第5單元《唱臉譜》教學設計
- 小學綜合實踐五年級上冊第2單元《社會服務》教材分析及全部教案
- 高質(zhì)量SCI論文入門必備從選題到發(fā)表全套課件
評論
0/150
提交評論